FDA Drug Application (017876) for LOESTRIN 21 1/20 by APIL

Back to FDA Applications sponsored by APIL

Application Number017876
Product Number001
FormTABLET;ORAL-21
Dosage0.02MG;1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOESTRIN 21 1/20
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by APIL